NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+25.16%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.46B
AUM Growth
+$1.46B
(+11%)
Cap. Flow
-$9.7M
Cap. Flow
% of AUM
-0.66%
Top 10 Holdings %
Top 10 Hldgs %
25.13%
Holding
226
New
28
Increased
57
Reduced
41
Closed
25
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$31.6M |
| 2 |
Merck
MRK
|
$28.3M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
$23.7M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$23.1M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$13.6M |
Top Sells
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$29.3M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$28.4M |
| 3 |
United Therapeutics
UTHR
|
$26.8M |
| 4 |
Sarepta Therapeutics
SRPT
|
$25.8M |
| 5 |
Insulet
PODD
|
$23.6M |
Sector Composition
| 1 | Healthcare | 53.92% |
| 2 | Technology | 13.34% |
| 3 | Industrials | 8.74% |
| 4 | Consumer Discretionary | 4.85% |
| 5 | Energy | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Krystal Biotech
KRYS
$4.27B
| $44M | 3.01% | 374,951 +233 | +0.1% | +$27.4K |
|
2
Legend Biotech
LEGN
$6.41B
| $40.9M | 2.8% | 593,167 -22,166 | -4% | -$1.53M |
|
3
Apellis Pharmaceuticals
APLS
$3.48B
| $37.8M | 2.58% | 414,419 +77,468 | +23% | +$7.06M |
|
4
Inspire Medical Systems
INSP
$2.77B
| $37.4M | 2.56% | 115,187 -3,671 | -3% | -$1.19M |
|
5
argenx
ARGX
$43.6B
| $37.2M | 2.54% | 95,414 -23,211 | -20% | -$9.05M |
|
6
Establishment Labs
ESTA
$1.2B
| $36.8M | 2.51% | 536,015 +79,531 | +17% | +$5.46M |
|
|
KDNY
7
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $35.7M | 2.44% | 928,637 -43,554 | -4% | -$1.67M |
|
|
KRTX
8
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $33.8M | 2.31% | 155,930 +108 | +0.1% | +$23.4K |
|
|
SWAV
9
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $32.3M | 2.21% | 112,999 +92 | +0.1% | +$26.3K |
|
|
ITCI
10
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $31.6M | 2.16% | +499,503 | New | +$31.6M |
|
11
Transmedics
TMDX
$3.92B
| $30.9M | 2.11% | 367,631 +223 | +0.1% | +$18.7K |
|
|
12
Xenon Pharmaceuticals
XENE
$2.98B
| $30.5M | 2.08% | 791,118 +354,403 | +81% | +$13.6M |
|
13
Axsome Therapeutics
AXSM
$6.05B
| $28.4M | 1.94% | 394,884 +54,454 | +16% | +$3.91M |
|
|
14
Merck
MRK
$210B
| $28.3M | 1.93% | +244,934 | New | +$28.3M |
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $28.2M | 1.93% | 80,116 -10,175 | -11% | -$3.58M |
|
16
Day One Biopharmaceuticals
DAWN
$769M
| $26.7M | 1.83% | 2,237,111 +633,721 | +40% | +$7.57M |
|
|
VRNA
17
Verona Pharma
VRNA
$9.16B
| $24.6M | 1.68% | 1,163,355 +222,055 | +24% | +$4.69M |
|
|
18
Mirum Pharmaceuticals
MIRM
$3.71B
| $23.7M | 1.62% | +915,119 | New | +$23.7M |
|
|
IMGN
19
DELISTED
Immunogen Inc
IMGN
| $23.1M | 1.58% | +1,224,127 | New | +$23.1M |
|
20
Vaxcyte
PCVX
$4B
| $23M | 1.57% | 460,164 +26,364 | +6% | +$1.32M |
|
21
Roivant Sciences
ROIV
$8.15B
| $22.8M | 1.56% | 2,265,323 +1,192,940 | +111% | +$12M |
|
22
Lantheus
LNTH
$3.73B
| $22.6M | 1.55% | 269,769 -108,336 | -29% | -$9.09M |
|
23
Cytokinetics
CYTK
$4.23B
| $22.3M | 1.52% | 682,867 +71,877 | +12% | +$2.34M |
|
24
Monolithic Power Systems
MPWR
$40B
| $19.5M | 1.33% | 36,047 -3,796 | -10% | -$2.05M |
|
|
DICE
25
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $19.3M | 1.32% | 416,151 | – | – |
|